Cavanaugh Group, Inc.’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Cavanaugh Group, Inc.'s IOVA Position: Q3 2026 in Review
Cavanaugh Group, Inc. opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 300 shares worth $2.45K. The stake represents ﹤0.01% of the portfolio and ranks #139 among its holdings.
334 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- Cavanaugh Group, Inc. held 300 shares of Iovance Biotherapeutics worth $2.45K as of Q3 2026.
- Iovance Biotherapeutics was a new Cavanaugh Group, Inc. position in Q3 2026.
- Iovance Biotherapeutics made up ﹤0.01% of Cavanaugh Group, Inc.'s portfolio in Q3 2026, its #139 holding.
- 334 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on Cavanaugh Group, Inc.'s 13F filing for Q3 2026, filed 17 Nov 2026.